Keyphrases
Tumor-associated
100%
Gastric Adenocarcinoma
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
100%
Myofibroblast
100%
Gastric Cancer
27%
Precancerous Lesions
18%
Subcellular Localization
9%
Small Fraction
9%
Cancer Metastasis
9%
Matrix Metalloproteinases
9%
Cancer Invasion
9%
Tumor-node-metastasis Stage
9%
Significant Trend
9%
Cancer Cells
9%
In Situ Hybridization
9%
Expression Pattern
9%
Mucosa
9%
Histological Subtypes
9%
Chromogranin A
9%
Hybrid Analysis
9%
Immunohistochemistry
9%
Invasive Front
9%
Fibroblast-like
9%
Extracellular Matrix
9%
Inconsistency
9%
Stromal Tissue
9%
Tumor
9%
Medicine and Dentistry
Neoplasm
100%
Tissue Inhibitor of Metalloproteinase 1
100%
Myofibroblast
100%
Stomach Adenocarcinoma
100%
Abdominal Cancer
27%
Cancer Cell
18%
Metastatic Carcinoma
18%
Messenger RNA
18%
Chromogranin A
9%
Cell Invasion
9%
Extracellular Matrix
9%
Fibroblast
9%
Matrix Metalloproteinase
9%
Malignant Neoplasm
9%
Immunohistochemistry
9%
In Situ Hybridization
9%
Mucosa
9%
Pharmacology, Toxicology and Pharmaceutical Science
Tissue Inhibitor of Metalloproteinase 1
100%
Neoplasm
100%
Stomach Adenocarcinoma
100%
Malignant Neoplasm
27%
Abdominal Cancer
27%
Messenger RNA
18%
Matrix Metalloproteinase
9%
Chromogranin A
9%
Biochemistry, Genetics and Molecular Biology
Myofibroblast
100%
Metalloprotease Inhibitor
100%
Cancer Cell
18%
Messenger RNA
18%
Subcellular Localization
9%
Fibroblast
9%
Chromogranin A
9%
Mucosa
9%
Cell Invasion
9%
Matrix Metalloproteinase
9%
In Situ Hybridization
9%
Agricultural and Biological Sciences
Myofibroblast
100%
Metalloprotease Inhibitor
100%
Messenger RNA
18%
Extracellular Matrix
9%
In Situ Hybridization
9%
Chromogranin A
9%
Immunohistochemistry
9%
Subcellular Localization
9%
Metalloproteinase
9%
Fibroblast
9%
Mucous Membrane
9%
Immunology and Microbiology
Myofibroblast
100%
Cancer Cell
40%
Cellular Distribution
20%
Extracellular Matrix
20%
Cell Invasion
20%
Fibroblast
20%
In Situ Hybridization
20%
Mucosa
20%